National and Kapodistrian University of Athens
Νευροπροστατευτικές ενώσεις με αντιοξειδωτικές και σιδηροδεσμευτικές ιδιότητες
Abstract
dc:descriptionIn the last two decades, an intense scientific interest has developed regarding neurodegenerative diseases of the Central Nervous System. Degenerative diseases of the Central Nervous System such as Parkinson's, Alzheimer's, Huntington's, Batten's and Pick's, multiple sclerosis, dementia with Lewy bodies, amyotrophic lateral sclerosis, now affect a significant proportion of the population of modern Western societies, which is expected to increase in the coming years as the average life expectancy increases. The most characteristic feature of neurodegenerative diseases is the generation of free radicals, therefore oxidative stress. Oxidative stress is responsible for the dysfunction or death of nerve cells thereby contributing to the pathogenesis of acute and chronic diseases and can be described as a "disturbance in the balance of pro-oxidant and anti-oxidant compounds, with a bias towards pro-oxidants", thereby potentially causing damage to the cell/organism. Additionally, neurodegenerative diseases have been linked to dysfunction in iron metabolism. Iron can increase the production of free radicals through the Fenton reaction, causing oxidative stress. The aim of this thesis was the design and synthesis of new neuroprotective compounds with antioxidant and iron-chelating activity. In particular, the design of new compounds was based on the two important strategies of Medicinal Chemistry: the development of hybrid drugs and bioisosteric substitution. The data that were taken into account for the design of the new chroman/catechol hybrids, substituted at position 2 or 5 of the benzopyran ring of vitamin E as well as tropolone analogs substituted at position 7, were: a) the strong antioxidant and neuroprotective activity displayed by the vitamin E (or tocopherol) and b) the antioxidant and iron-binding activity of polyphenols and tropolones. New chroman/catechol hybrids were designed and synthesized, in which the amide bond in position 2 or 5 of the benzopyran ring of the first generation compounds (these were amide analogs), was replaced by heterocyclic five-membered rings, which are bioisosteres of amide bond, such as 1,2,4 and 1,3,4-oxadiazoles, 1,2,3-triazoles, isoxazole analogs, tetrazole analogs. 7-Substituted tropolone derivatives whose substituents contain nitrogen-containing aliphatic, heterocyclic rings were also designed and synthesized. The new hybrid analogs were studied for their cytoprotective and neuroprotective activity in HT22 cells under glutamate-induced oxidative stress. HT22 cells do not express functional ionotropic glutamic acid receptors, so they show cytotoxicity only due to oxidative stress and not due to stimulation. The new analogs showed strong neuroprotective activity with antioxidant and iron-binding properties.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Theodorou, Elissavet
- Θεοδώρου, Ελισσάβετ
Subjects
dc:subject × 18- Νευροπροστατευτικές ενώσεις
- Αντιοξειδωτικές ιδιότητες
- Σιδηροδεσμευτικές ενώσεις
- Κατεχόλες
- Τροπολόνες
- Οξειδωτικό στρες
- Neuroprotective analogues
- Antioxidant activity
- Iron-chelating activity
- Catechols
- Tropolones
- Oxidative stress
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, άλλοι τομείς
- Health Sciences
- Medical and Health Sciences
- Health sciences, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51305